Boston, MA · Founded 2019 · Privately Held (backing)
Developer of an artificial intelligence-based neurotechnology platform designed for accelerating the clinical development of therapeutics targeting brain health. Beacon Biosignals is based in Boston, MA and was founded in 2019. It was valued at $334 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $127 million across 2 recorded rounds; the latest was a $103 million later-stage round in Oct 2025.
PMV mark · valuation
$334.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$126.9M
Last round
Later Stage VC
Oct 2025
Cap table — not yet on record
Beacon Biosignals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Beacon Biosignals with a free account
·The complete investor list: 20 names
·Watch Beacon Biosignals: the Monday email on marks, rounds and moves
Where does Beacon Biosignals's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Beacon Biosignals's 2 recorded funding rounds.
